Literature DB >> 2868387

Transglutaminases.

J E Folk, S I Chung.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 2868387     DOI: 10.1016/s0076-6879(85)13049-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  31 in total

1.  Characterization and large-scale production of recombinant Streptoverticillium platensis transglutaminase.

Authors:  Shie-Jea Lin; Yi-Fang Hsieh; Li-An Lai; Mei-Li Chao; Wen-Shen Chu
Journal:  J Ind Microbiol Biotechnol       Date:  2008-05-24       Impact factor: 3.346

2.  Post-translational modification of apolipoprotein B by transglutaminases.

Authors:  E Cocuzzi; M Piacentini; S Beninati; S I Chung
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

3.  Transglutaminase-induced cross-linking between subdomain 2 of G-actin and the 636-642 lysine-rich loop of myosin subfragment 1.

Authors:  L Eligula; L Chuang; M L Phillips; M Motoki; K Seguro; A Muhlrad
Journal:  Biophys J       Date:  1998-02       Impact factor: 4.033

4.  Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases.

Authors:  Asaf Sol; Yaniv Skvirsky; Rizan Nashef; Katya Zelentsova; Tal Burstyn-Cohen; Edna Blotnick; Andras Muhlrad; Gilad Bachrach
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

5.  A rapid and simple method for the purification of transglutaminase from Streptoverticillium mobaraense.

Authors:  U Gerber; U Jucknischke; S Putzien; H L Fuchsbauer
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

6.  Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation.

Authors:  Bijan Ahvazi; Hee Chul Kim; Sun-Ho Kee; Zoltan Nemes; Peter M Steinert
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

7.  Molecular mechanisms of posterior vitreous detachment.

Authors:  J Akiba; N Ueno; B Chakrabarti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-07       Impact factor: 3.117

8.  A novel therapeutic target in inflammatory uveitis: transglutaminase 2 inhibitor.

Authors:  Joonhong Sohn; Ju Byung Chae; Sun Young Lee; Soo-Youl Kim; June-Gone Kim
Journal:  Korean J Ophthalmol       Date:  2010-02-05

9.  Serum-induced collagen gel contraction.

Authors:  J Akiba; A Kakehashi; N Ueno; Y Tano; B Chakrabarti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

10.  Autoantibodies of patients with coeliac disease are insufficient to block tissue transglutaminase activity.

Authors:  W Dieterich; D Trapp; B Esslinger; M Leidenberger; J Piper; E Hahn; D Schuppan
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.